Skip to main content
. 2021 Mar 11;107(3):593–603. doi: 10.3324/haematol.2020.274456

Table 3.

Classification of patients in the previously suggested risk categories according to the number of aberrations detected by chromosome banding analysis and genomic microarrays.

graphic file with name 107593.tab3.jpg